Media 30 Sep 2022 Stockhead Investor Guide | September 2022 Orthocell was featured in the widely read column, Dr Boreham’s Crucible, written by respected small cap analyst and business journalist,… Orthocell
Company News 29 Sep 2022 Ortho-ATI™ Shoulder Tendon Study Update Orthocell has today shared positive results from the crossover extension arm of our randomised clinical trial examining the performance of… Orthocell
Company News 27 Sep 2022 First orders for dental and nerve products Orthocell has now received first purchase orders for our flagship collagen medical device products Striate+™ and Remplir, via our valued… Orthocell
Audio, Media 13 Sep 2022 Beyond the Medicine Cabinet Podcast | September 2022 Orthocell’s CEO and Managing Director Paul Anderson has featured on Beyond The Medicine Cabinet podcast to talk about regenerative nerve… Orthocell
Media, Video 07 Sep 2022 VIDEO | Proactive Investors – September 2022 Orthocell’s Paul Anderson spoke with Andrew Scott at Proactive Investors to discuss to discuss the announcement that the Company had… Orthocell
Media, Video 07 Sep 2022 Orthocell appoints Device Technologies as distributor of its nerve repair device in Aus, NZ Orthocell's distribution deal with Device Technologies has been featured in The West Australian, in this news article by business reporter… Orthocell
Company News 07 Sep 2022 Appointment of exclusive distributor of Remplir™ in Australia Orthocell has appointed Device Technologies as the exclusive distributor of Remplir™ for peripheral nerve repair in Australia. Orthocell
